Perez, M., Lucena-Cacace, A., Marín-Gómez, L. M., Padillo-Ruiz, J., Robles-Frias, M. J., Saez, C., . . . Carnero, A. (2016). Correction: Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-Src. Oncotarget.

Perez, Marco, Antonio Lucena-Cacace, Luis Miguel Marín-Gómez, Javier Padillo-Ruiz, Maria Jose Robles-Frias, Carmen Saez, Rocio Garcia-Carbonero, ja Amancio Carnero. "Correction: Dasatinib, a Src Inhibitor, Sensitizes Liver Metastatic Colorectal Carcinoma to Oxaliplatin in Tumors With High Levels of Phospho-Src." Oncotarget 2016.

Perez, Marco, et al. "Correction: Dasatinib, a Src Inhibitor, Sensitizes Liver Metastatic Colorectal Carcinoma to Oxaliplatin in Tumors With High Levels of Phospho-Src." Oncotarget 2016.